Technology News and Headlines

Call Goes Out for Type 1 Diabetes Screening in UK

Researchers from the University of Birmingham reported that the ELSA feasibility trial screened roughly 17,000 UK children aged three to 13 using a finger‑prick autoantibody test, identifying early‑stage type 1 diabetes before symptoms appear. The study found 75 children with a single autoantibody and 160 with multiple autoantibodies, and seven undiagnosed cases were started on insulin immediately. Results suggest a national screening programme could prevent up to 25% of diabetic ketoacidosis cases and enable timely treatment with drugs like Sanofi’s Teizeild. The team is expanding to older ages and evaluating cost‑effectiveness for NHS rollout.